Lv1
20 积分 2023-12-22 加入
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
9天前
已完结
Glucagon-like peptide 1 in health and disease
9天前
已完结
Dual targeting of cutaneous inflammation and vasculopathy via STING-NF-κB blockade underlies the anti-psoriatic efficacy of Yinxie Granules
1个月前
已完结
Zexieyin formula attenuates Alzheimer’s disease via suppressing A1 astrocyte activation: A serum pharmacochemistry and network pharmacology study
6个月前
已完结
Microneedle Patch Delivering Multifunctional Melanin-like Nanoparticles for Vitiligo Remission and Repigmentation
7个月前
已完结
Advances in the Application of Traditional Chinese Medicine Using Artificial Intelligence: A Review
10个月前
已完结
[Research progress in the regulation of autophagy and mitochondrial homeostasis by AMPK signaling channels]
1年前
已完结
皖公网安备34019202002308
